Thermo Fisher Scientific Inc.
TMO
$512.69
$4.590.90%
NYSE
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.96B | 1.62B | 1.62B | 1.51B | 1.83B |
| Total Depreciation and Amortization | 728.00M | 671.00M | 676.00M | 705.00M | 742.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 318.00M | 56.00M | -168.00M | -64.00M | 124.00M |
| Change in Net Operating Assets | 447.00M | -104.00M | -726.00M | -1.43B | 594.00M |
| Cash from Operations | 3.46B | 2.24B | 1.40B | 723.00M | 3.29B |
| Capital Expenditure | -465.00M | -404.00M | -294.00M | -362.00M | -480.00M |
| Sale of Property, Plant, and Equipment | 27.00M | 4.00M | 1.00M | 12.00M | 17.00M |
| Cash Acquisitions | 0.00 | -4.04B | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.33B | 314.00M | 5.00M | -177.00M | 483.00M |
| Cash from Investing | 891.00M | -4.12B | -288.00M | -527.00M | 20.00M |
| Total Debt Issued | 4.92B | 1.10B | 0.00 | 2.84B | 0.00 |
| Total Debt Repaid | -1.29B | -597.00M | -787.00M | -838.00M | -2.50B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -37.00M | -963.00M | 0.00 | -2.00B | -1.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -162.00M | -163.00M | -162.00M | -149.00M | -149.00M |
| Other Financing Activities | 91.00M | -4.00M | -42.00M | 45.00M | -17.00M |
| Cash from Financing | 3.53B | -632.00M | -991.00M | -102.00M | -3.67B |
| Foreign Exchange rate Adjustments | -6.00M | -75.00M | 311.00M | 37.00M | -273.00M |
| Miscellaneous Cash Flow Adjustments | -- | -1.00M | 0.00 | 1.00M | -1.00M |
| Net Change in Cash | 7.87B | -2.59B | 431.00M | 132.00M | -630.00M |